#Hypospadias Surgery Cost in India

[ankurahospitalvijayawada]

Hypospadias is a clinical group of best Hypospadias Surgeon in India and as a surgical issue has enchanted the surgeons and the patients since time immemorial. In the past, hypospadias operations have had very poor success rates. Then after some time, the fact was accepted that the Hypospadias surgery needs to be done by a Surgeon who specializes in Hypospadias Surgery, namely a Hypospadiologist. One of the best Hypospadias Surgery Doctor in India are available at Ankura hospital.

Hypospadias is a congenital (birth) defect found in a male child. In this condition, the opening of urethra is not placed at the penis's tip. The urethra originates abnormally during 8-14 weeks of pregnancy. This abnormal opening is usually anywhere, beginning from just below the end of the penis to the scrotum. The condition can only be treated by the best Hypospadias Surgery in India.

Types of Hypospadias: There are three types of hypospadias:

Subcoronal: The urethral opening is placed somewhere close to the penis head. Midshaft: The urethral opening is placed along the penis’s shaft. Penoscrotal: The urethral opening is placed where the penis meets scrotum.

Symptoms of Hypospadias: The common signs and symptoms of hypospadias are: Beneath curved penis (chordee).

The opening of the urethra is placed in other sites than the penis's head. The hooded appearance of the penis when its upper half is covered by the foreskin. Unnatural spraying while urinating. These conditions can only be treated with the help of hypospadias surgery by the best Hypospadias Treatment Doctors in India.

Cause of Hypospadias: For many pediatric urologists, it's difficult to find the main cause of Hypospadias. Our Best Hypospadias Surgery Doctor in India at Ankura Hospital have recognized some of its main causes: Being obese or Overweight in pregnancy. Family history of Hypospadias Pregnancy after the age of 35. Undergoing IVF fertility treatment Errors or mutations in Genetic sequencing. Best Treatment for Hypospadias in Children In the case of mild hypospadias, when the urethral opening is just a little down from regular and there is no bending of the penis, treatment may not be required. However, in most cases, operation is needed to fix the hypospadias. It can be done in one operation. But, if the condition is more complicated, there may be a requirement of two operations. The best Treatment for Hypospadias in Children is majorly done when the child is about 6-18 months old.

Book an Appointment Now!

Ankura Hospital India is the best hypospadias surgeon nearby Best Hypospadias Surgeon in India, Best Hypospadias Surgeon near me, Best Hypospadias Surgery Doctor in India, Best Hypospadias Surgery in India, Best Hypospadias Treatment Doctors in India, Best Treatment for Hypospadias in Children, Best Surgery for Hypospadias Treatment, Hypospadias Surgery Cost in India, Best Hypospadias Surgery cost near me. For more information contact +91 9053 108 108.

[hypospadiasclinic]

Hypospadias, a common congenital abnormality affecting young boys, often necessitates repair surgery to improve quality of life and prevent psychological impact as they grow older. However, understanding the costs involved in this procedure is crucial for families considering treatment options.

In India, the cost of Hypospadias surgery can vary significantly, ranging from 30,000 to 2,00,0000 rupees, depending on several factors.

Firstly, the expertise and experience of the healthcare professional performing the surgery play a significant role in determining the cost. Surgeons with more experience and higher success rates typically charge higher fees.

2.The method of surgery also influences the cost. Advanced techniques such as laparoscopy may incur higher expenses compared to conventional open surgeries due to their precision and minimally invasive nature.

3.The type and severity of Hypospadias are critical factors affecting the cost. Cases with higher severity may require more time and involve greater complexity, resulting in higher surgical expenses.

4.Additionally, patient-specific factors such as age, physiological conditions, and medical history can impact the treatment plan and, consequently, the cost of surgery. Complications or previous failures may also require additional resources and expertise, contributing to overall expenses.

Ultimately, while cost is an important consideration, prioritising the expertise and experience of the healthcare provider and ensuring the best possible outcome for the patient should be paramount.

[specialisthospitals]

Hypospadias Surgery Cost in Kerala

hypospadias surgery is a type of penis reconstruction treatment, the treatments are tip hypospadias repair, glanular hypospadias coronal hypospadias repair

info@specialistshospital.org

[mtcentre-blog]

TREATMENT

Hypospadias is completely treatable. However, it is completely treated in stages depending upon the severity of the condition and associated complications.

Hypospadias is treated by surgical intervention and necessarily needed to be operated. Ideally, the surgery is often performed during the first year of a boy’s life for a better clinical outcome.

The objective of the hypospadias repair is to:

· Correct the downward curvature,

· Reconstruct the urethra so that the urethra is of adequate size and with the opening at the usual place i.e, at the tip of the penis,

· Provide a normal cosmetic appearance of the penis.

[ankurahospitals-blog]

Hypospadias is a common abnormality of the penis. It occurs in 1 out of every 150-200 boys. Hypospadias leads to both cosmetic and functional problems. 

The main features of hypospadias are an abnormally situated urinary opening (situated on the undersurface of the penis, instead of being at the tip of the penis normally), a penis that is bent downwards (which is called chordee), an abnormal foreskin and abnormal glans penis (glans is the cone-shaped terminal part of the penis). There are many types of hypospadias, based on the severity of each of these defects.

For More Info Please Visit:  Hypospadias Treatment & Management

[industryinsights]

Urethral Stricture Market Size, Competitive Landscape, Growth Factors, Revenue Analysis Till 2027

Market Research Future’s (MRFR) latest report predicts that the global urethral stricture market size is projected to surge at a CAGR of 7.30% during the forecast period. Urethral stricture is a chronic disease which can narrow the urethral opening due to injuries, scars, genetic disorders and sexually transmitted diseases. This can restrict urine flow and be a major cause of various urological disorders.

The urethral stricture market is expanding steadily due to the rise in the treatment of injuries, kidney stones, poor dietary habits, obesity, and other medical conditions that require urethral stents, dilators, and catheters. Apart from this, improving healthcare facilities and growing awareness about the disease and treatment positively affect the market size globally. Surgeries like urethral dilations are popular in countries like India and China due to their high efficiency and low cost. Furthermore, the introduction of new and advanced medications and treatments is likely to boost the market growth during the forecast period.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6001

On the flip side, restraints opposing the market growth include lack of knowledge about the disease and minimal access to medical facilities. Despite the restraints, major drivers such as growing penetration by market players and elevating need to gain access to affordable treatments are likely to boost the market size in the coming years.

Technological advancements such as tissue engineering is the latest trend changing the dynamics of the market. Due to tissue engineering technology, surgeons are no longer limited by the quantity and quality of urethral substitutes existing in a patient. 

Global Market for Urethral Stricture– Segmental Analysis

According to the report, the urethral strictures market is segmented on the basis of type, condition, cause, treatment, gender, end-user, and region.

By type, the market is segmented into posterior urethral stricture and anterior urethral stricture. The posterior urethral stricture segment currently holds the maximum market share and likely to continue its dominance throughout the forecast period. Growing injuries such as pelvic fractures, and an increasing number of patients undergoing treatment for prostate cancer drives the posterior urethral stricture market across the globe.

Based on condition, the market is segmented into hypospadias & epispadias, urinary incontinence, and others. The hypospadias & epispadias segment was worth more than USD 468.8 million in 2017. Increasing birth defects, elevating hormonal malfunctions, and large male population are factors expediting the market expansion across the globe.

By cause, the market is segmented into iatrogenic, idiopathic, infection-induced, and trauma. In 2017, the iatrogenic segment accrued over USD 284.0 million. Primary drivers for the growth of iatrogenic segment are increasing public awareness about the disease, growing pharmaceutical companies, and advancement in medical technology.

Based on treatment, the market is segmented into urethral dilation, direct vision internal urethrotomy (DVIU), urethroplasty, and others. The urethroplasty market is leaping ahead due to evolving surgical treatments and a growing number of skilled medical surgeons.

By gender, the market pertains to male and female. The male segment held the largest market share in 2017. Anatomically, males are more prone to urethral strictures than females due to the presence of longer urethras and being more susceptible to injury and infections.

The end-users in the urethral strictures market are hospitals, urologic clinics, ambulatory surgical centers, and others. The hospitals segment is expected to retain its dominance over the market share throughout the forecast period.

Regional Outlook

Geographically, the market is spread across North and South America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The America region presently holds the largest market share and will continue its lead in the coming years. The market growth in the region is due to sophisticated treatment provided by health facilities in both the United States (U.S) and other Latin American countries. Also, the medical device industry is thriving and holds massive potential for further growth in the US. Moreover, innovative technology and frequent product development in the region give way to the growth of the market. Recently, surgeons in North America developed a new smartphone-based tool that detects a urethral blockage, which is convenient for patients to test themselves for the condition at home.

The Europe market is expected to grow significantly during the forecast period owing to owing to the high availability of advanced treatment facilities and healthcare expenditure. Furthermore, increasing population prone to diseases also fuel the market growth.

Asia Pacific market’s upward trajectory can be attributed to growing expensive equipment and infrastructure, and increasing research and development initiatives to improve the quality and effectiveness of new and modern instrumentations. Countries such as India and China contribute massively to the market expansion owing to the rapid development of healthcare infrastructure and surging demand for diagnostic and treatment services.

On the other hand, the Middle East and Africa market is expected to experience a steady growth rate driven by the growing availability of new and advanced diagnostic and treatment methods.

Global Market for Urethral Stricture – Competitive Dashboard

The key players mentioned in the report are Stryker Corporation, Lumentis Ltd, Boston Scientific Corporation, Olympus Corporation Bard Medical, and Cook Medical Incorporated, Cook Medical, Richard Wolf, SRS Medical, and others.

Access Report @ https://www.marketresearchfuture.com/reports/urethral-stricture-market-6001

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[martynnx-blog]

Urethral Stricture Treatment Market Improvement in Technology is Expected to Drive the Growth of the Market

Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence of a scar tissue, tissue inflammation, infection or injury. This condition can cause obstructive dysfunction of urethra with potentially serious consequences for the entire urinary tract. The urinary strictures are more common in males. They occur at any point along the urethra, but are most often seen in the bulbar region and can range from less than 1cm long to the entire length of the urethra. There are two types of urethral stricture conditions that occur in males, which include posterior and anterior urethral strictures.

Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2381

The cause of urethral stricture depends on the site of the stricture. Some of the common causes for this condition are idiopathic, inflammatory (caused by infection or chronic inflammation in urethra, e.g., lichen sclerosus), traumatic (caused due to injury to the urethra), iatrogenic (caused by medical intervention such as endoscopic procedures, urethral catheterization, radiotherapy or surgery to neighboring organs), and congenital (caused by inherited conditions such as hypospadias and epispadias).

Some of the common symptoms of urethral strictures includes painful urination, reduced urine output, incomplete emptying of the bladder, and inability to void. There are various types of treatment available for urethral strictures ranging from conservative or minimally invasive procedures to complex reconstructive procedures such as direct vision internal urethrotomy (DVIU), urethroplasty, urethral dilation, and others.

Urethral Stricture Treatment Market – Market Dynamics

Increasing cases of prostate cancers, injuries, and medical conditions requiring urethral stents, dilators, and catheters is one of the major factors for rise in urethral stricture cases, which in turn is driving growth of the urethral stricture treatment market.

According to the National Centers for Biotechnology & Information (NCBI), urethral stricture is a common disease with prevalence of over 400 per 100,000 population among males in year 2016 globally.  According to the Cancer Research UK, in males in the U.K., prostate cancer is the most common cancer with around 47,200 new cases registered in 2015. Moreover, the incidence rates of prostate cancer are projected to rise by 12% between 2014 and 2035, to 233 cases per 100,000 males by 2035 in the U.K., as per Cancer Research UK. High catheter associated urinary tract infection (CAUTI) rates of 6.8 per 1000 device days were observed in the UAE medical units in March 2015.

Moreover, advancements in development of therapies for treating urethral strictures is driving growth of the urethral stricture treatment market. For instance, a Germany-based company, MukoCell GmbH developed a tissue engineering-based product called MukoCell, which is used for repair of urethral strictures and hypospadias. This product is an alternative to conventional transplantation with native buccal mucosa.

However, high cost of surgical procedures and high rate of complications are some of the major factors restraining growth of the global urethral stricture treatment market. According to Healthcare Cost and Utilization Project (HCUP) 2016, the average cost of male urethroplasty can range between US$ 5,677–US$ 10,000 with an average increase of US$ 616 per year in the U.S.

Urethral Stricture Treatment Market – Regional Insights

On the basis of geography, the global urethral stricture treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held dominant position in the global urethral stricture treatment market in 2017. This is owing to rising number of urethroplasties for urethral strictures in the region. Moreover, high adoption rate of innovative technologies and numerous product development is driving growth of the market. For instance, in February 2018, Urotronic, an early stage medical device company, received license for its product, Optilume drug-coated balloon (DCB), which will be used to treat urethral strictures in Canada. The development of this drug-coated ballon have a significant impact across Canada due to scarcity of physicians currently to perform majority of urethral stricture treatments.

Asia Pacific is expected to witness significant growth in the urethral stricture treatment market during the forecast period, owing to improving health care infrastructure in economies such as India and China, and increasing demand for efficient treatment options for urethral strictures.

Urethral Stricture Treatment Market – Competitive Landscape

Major players operating in the global urethral stricture treatment market include C. R. Bard, Inc., Amecath, Uromed, MedNova, Allium Medical, Surgimedik, Cook Medical Inc., Mednova, Taewoong Medical, Teleflex Incorporated, B. Braun Holding GmbH & Co. KG, Urotech, Coloplast Ltd, Boston Scientific Corporation, and Pnn Medical A/S. Key players are focusing on expanding their product portfolio, in order to retain dominant position in the market. For instance, Allium Medical, which manufactures and markets minimally invasive products, entered into the market with its product, Allium’s Ureteral Stents, which has some unique composition and better bio-compatibility.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2381

[myabhijitr]

Urethral Stricture Treatment Market Size, Growth, Outlook, and Analysis, 2018 – 2026

Urethral stricture is a medical condition, which causes narrowing of the urethra due to presence of a scar tissue, tissue inflammation, infection or injury. This condition can cause obstructive dysfunction of urethra with potentially serious consequences for the entire urinary tract. The urinary strictures are more common in males. They occur at any point along the urethra, but are most often seen in the bulbar region and can range from less than 1cm long to the entire length of the urethra. There are two types of urethral stricture conditions that occur in males, which include posterior and anterior urethral strictures.

The cause of urethral stricture depends on the site of the stricture. Some of the common causes for this condition are idiopathic, inflammatory (caused by infection or chronic inflammation in urethra, e.g., lichen sclerosus), traumatic (caused due to injury to the urethra), iatrogenic (caused by medical intervention such as endoscopic procedures, urethral catheterization, radiotherapy or surgery to neighboring organs), and congenital (caused by inherited conditions such as hypospadias and epispadias).

Access Full Summary at: https://www.coherentmarketinsights.com/ongoing-insight/urethral-stricture-treatment-market-2381

Market Dynamics

Increasing cases of prostate cancers, injuries, and medical conditions requiring urethral stents, dilators, and catheters is one of the major factors for rise in urethral stricture cases, which in turn is driving growth of the urethral stricture treatment market.

According to the National Centers for Biotechnology & Information (NCBI), urethral stricture is a common disease with prevalence of over 400 per 100,000 population among males in year 2016 globally. According to the Cancer Research UK, in males in the U.K., prostate cancer is the most common cancer with around 47,200 new cases registered in 2015. Moreover, the incidence rates of prostate cancer are projected to rise by 12% between 2014 and 2035, to 233 cases per 100,000 males by 2035 in the U.K., as per Cancer Research UK. High catheter associated urinary tract infection (CAUTI) rates of 6.8 per 1000 device days were observed in the UAE medical units in March 2015.

Moreover, advancements in development of therapies for treating urethral strictures is driving growth of the urethral stricture treatment market. For instance, a Germany-based company, MukoCell GmbH developed a tissue engineering-based product called MukoCell, which is used for repair of urethral strictures and hypospadias. This product is an alternative to conventional transplantation with native buccal mucosa.

However, high cost of surgical procedures and high rate of complications are some of the major factors restraining growth of the global urethral stricture treatment market. According to Healthcare Cost and Utilization Project (HCUP) 2016, the average cost of male urethroplasty can range between US$ 5,677–US$ 10,000 with an average increase of US$ 616 per year in the U.S.

Regional Insights

On the basis of geography, the global urethral stricture treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held dominant position in the global urethral stricture treatment market in 2017. This is owing to rising number of urethroplasties for urethral strictures in the region.

Asia Pacific is expected to witness significant growth in the urethral stricture treatment market during the forecast period, owing to improving health care infrastructure in economies such as India and China, and increasing demand for efficient treatment options for urethral strictures.

Urethral Stricture Treatment Market – Competitive Landscape

Major players operating in the global urethral stricture treatment market include C. R. Bard, Inc., Amecath, Uromed, MedNova, Allium Medical, Surgimedik, Cook Medical Inc., Mednova, Taewoong Medical, Teleflex Incorporated, B. Braun Holding GmbH & Co. KG, Urotech, Coloplast Ltd, Boston Scientific Corporation, and Pnn Medical A/S. Key players are focusing on expanding their product portfolio, in order to retain dominant position in the market. For instance, Allium Medical, which manufactures and markets minimally invasive products, entered into the market with its product, Allium’s Ureteral Stents, which has some unique composition and better bio-compatibility.

Download PDF Brochure of This Business Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2381

Urethral Stricture Treatment Market - Taxonomy

On the basis of type, the global urethral stricture treatment market is segmented into: Posterior Urethral Stricture, Anterior Urethral Stricture, On the basis of cause, the global urethral stricture treatment market is segmented into: Iatrogenic, Idiopathic, Infection-induced, Trauma, Others,. On the basis of diagnosis, the global urethral stricture treatment market is segmented into: Ultrasound, Urinalysis, Uri flow test, Pelvic ultrasound, Cystoscopy, Others ,.On the basis of treatment, the global urethral stricture treatment market is segmented into: Urethral Dilation, Direct Vision Internal Urethrotomy (DVIU), Urethroplasty, Others,. On the basis of geography, the global urethral stricture treatment market is segmented into: North America, Latin America, Europe, Asia Pacific, Middle East, Africa,.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

[digitaldezireclinic-blog]

Top 10 liposuction surgeon in Delhi

The demand of liposuction is increasing very rapidly, this is mainly due to the fact that everyone is now wants to get perfect shape of their body. We see peoples working day and night in gyms, yoga, aerobics for getting a perfect figure. Some people want to get perfect figure because they want to go in acting career or modelling. But in some cases it happens that they are not able to get the result inspite of their efforts. Liposuction is the best option for all those people who wants to get perfect shape of their body which they have not got through diet, exercises or any other means.

What is liposuction?

Liposuction is a surgical procedure which reduces the localized deposition of fat by only through a minute incision which fades with time. Liposuction is very effective in changing contour of the body because it reduces the number of number of fat cells which are not evenly distributed. Liposuction may not always prevent weight loss or weight gain but it equally distributes weight.

If you are planning for liposuction then you must want to get it done by the best liposuction surgeon. If you are in or near Delhi then this list will be very much beneficial to you.

Some of the Top liposuction surgeon in Delhi are:

Dr. Lokesh Kumar- He is a Senior Consultant Cosmetic and Plastic Surgeon in Delhi, India. He practices at BLK Super Speciality Hospital in Pusa Road, Delhi. Dr. Lokesh Kumar specializes in Cosmetic and Microvascular surgery. Dr. Lokesh Kumar has more than 26 years of experience. He is a qualified Cosmetic and Plastic Surgeon at BLK Hospital in Delhi. Patients from entire Delhi, India and across the globe come to Dr. Lokesh Kumar with lots of hopes and the doctor ensures that the patients are satisfied with the treatments, with his experience and techniques he uses with his expertise in Cosmetic and Plastic Surgery.

Dr. Shilpi Bhadani- She is a Cosmetic/Plastic Surgeon in Gurgaon. Dr. Shilpi Bhadani practices at SB Aesthetics, sector 42, Gurugram. She is a reputed expert in plastic surgery with specilaization in aesthetic and cosmetic surgery of face and body. Over the years she has performed numerous successful liposuction and chest reshaping surgeries, body contouring, tummy tuck and face reshaping, facelift, scar revision etc.

Dr. Prashant Yadav- Dr Prashant Yadav is an Indian Board Certified Plastic and Cosmetic Surgeon as well as member of the Association of Plastic Surgeons of India and Pune Association of Plastic Surgeons. Dr Prashant Yadav is dedicated to providing the highest quality cosmetic surgery in a friendly, private setting at an affordable price.  He has an experience of more than 10 years in this field and he is respected by his patients because of his excellent reputation and honesty.He is very thorough in his consultations and enjoys the one-on-one relationships he develops with his patients. He decision regarding cosmetic surgery. He is the Director of Dezire Clinic and his patients receive the highest standards of individually focused care. e is trained under the guidance of renowned body contouring surgeon Dr Alfredo Hoyos for VASER 4 D HI DEF liposuction .He has published various articles in international and national journals.

Dr. Prashant special interests include laser treatments, gynecomastia treatment, cosmetic surgery of the breast (including augmentation and breast lift), Rhinoplasty, abdominoplasty (tummy-tuck), VASER 4D HI DEF liposuction, cosmetic surgery of the face, autologous fat transfer, and body contouring surgery after massive weight loss.

Dr. Rohit Krishna- Dr. Rohit Krishna is a Plastic Surgeon in Vasant Kunj, Delhi and has an experience of 24 years in this field. He is a member of All India Association of Plastic Surgeons. Some of the services provided by the doctor are: Ear Reconstruction,Wrinkle Treatment,Thighplasty (Thigh Lift),Thread Lift and Dermatologic Surgery, Liposuction etc.

Dr. Tapeshwar Sehgal- Dr. Tapeshwar Sehgal is a plastic surgeon at new Delhi. He has the special interest is cosmetic surgeries after having operated on several cases of liposuction, all types of tummy tucking (abdominoplasty), breast enhancement & reduction surgeries, facial cosmetic surgeries, rhinoplasty, and gynecomastia correction.

Dr. Akshat Wahal- After receiving formal education from internationally renowned institutes AIIMS and Safdarjung, he has worked at high volume enters like Apollo Hospitals and gained extensive experience in difficult and challenging reconstructive and cosmetic surgeries especially in Liposuction, abdominoplasty (Tummy Tuck) and facial surgeries including face lifts and rhinoplasties.

Dr. Pradeep Kumar Singh- Dr Pradeep Kumar Singh is well known Plastic and Cosmetic surgeon in DELHI NCR. His main interest includes cosmetic surgery, microvascular surgery, head and neck reconstruction, hair transplant and congenital anamolies like cleft lip & palate and hypospadias. He is vastly experienced in managing ortho-trauma cases and post cancer surgery defects and performed micro-vascular reconstructions including digital and limb replantation. He is specialized in Hair transplant, Liposuction, Breast enlargement , Breast reduction including short scar procedures, Face Lift, Nose surgery, Botox etc in Delhi NCR.

Dr. Ritesh Anand- Dr Ritesh Anand is a Plastic & Cosmetic Surgeon at LA Midas the complete medical aesthetics and wellness centre at Main Mehrauli-Gurgaon Road near Guru Dronacharya Metro Station, DLF Phase 3, Gurugram, and Haryana. Dr Ritesh Anand has special interest in Hair Transplant, Liposuction, Gynecomastia, Blepharoplasty (Eyelid Surgery), Facelift, Rhinoplasty, Abdominoplasty (Tummy Tuck), Breast Augmentation, Breast Reduction and Cosmetic procedures like Chemical Peeling, Facial Rejuvenation, Dermabrasion, Acne and Acne scar treatment.

Dr. Monisha Kapoor- She is the Director of the clinic and the Chief Operating Surgeon is a renowned & reputed plastic surgeon of International class with practical, genuine & extensive experience and expertise in this thrilling field. She is distinguished to be associated with the International Society of Aesthetic plastic surgery and has been an active member of the prestigious organization. She has got herself thoroughly trained from the masters across the world giving the latest and the best to her patients at costs half the international price.

[bhagyashribhole123]

Global Urethral Stricture Market Drivers, Segmentations, Key Players, Analysis & Forecast 2019 - 2023

Market Insights

The global Urethral Stricture Market research report presents a comprehensive study that states that it is expected to achieve a valuation of USD 1.53 billion by 2023 at a rate of 7.30% CAGR. The rapid proliferation of the market has been recorded by Market Research Future Reports analysts, who did a depth analysis of the market during the assessment period. The report also includes the market’s driving factors, expansion, challenges, trends and regional share across the globe.

Urethral stricture is considered to be a chronic disease which narrows the urethral opening caused due to injuries, scars, genetic disorders, and sexually transmitted diseases. The occurrence of any of such diseases, hence, restricts the flow of urine and causes various urological disorders. It is much more common in men than in women, and there need proper care and treatment.

Thus, the urethral stricture market is intensifying steadily owing to the rise in the treatments of injuries, and chronic problems such as kidney stones, poor dietary habits, obesity, and other medical conditions.

Key Market Players

Market Research Future Reports have listed some of the key players, who are named as Stryker Corporation, Lumentis Ltd, Boston Scientific Corporation, Olympus Corporation Bard Medical, and Cook Medical Incorporated, Cook Medical, Richard Wolf, SRS Medical, and others.

Global Urethral Stricture Market: Drivers & Trends

The global urethral strictural market is driven by factors such as the increasing occurrence of urethral strictures, rising cases of urolithiasis in adults, and the mounting frequency of urinary incontinence. With such diseases entering in people’s life, healthcare facilities are bound to increase their pace for providing complete treatment to patients. Also, growing awareness about the disease and favorable treatments are encouraging the urethral structural market to expand exponentially. The best part of its treatment goes to surgeries like urethral dilations, which are popular in countries such as India and China. These surgeries cost lower than others and are considered to be of high efficiency. Therefore, these factors are mainly contributing to cultivate the market in recent years, whereas it is also expected that the market will expand with more and more opportunities in the coming years.

On the other part, the introduction of new and advanced medications and treatments is highly possible to boost the market growth during the forecast period. Advanced medication includes a rising occurrence of hypospadias, which is one of the major interests for healthcare providers, clinical medicines, and research. Hypospadias is referred to common congenital malformation that requires surgical repair, whereas, its long-term management requires a substantial amount of socioeconomic resources. Such advance research enabled high technological treatments that surged the market position at a higher CAGR globally.

Furthermore, technological advancements such as tissue engineering are the modern trend changing the dynamics of the market. Due to tissue engineering technology, surgeons are no longer limited by the quantity and quality of urethral substitutes existing in a patient.

Browse More Information @ https://www.marketresearchfuture.com/reports/urethral-stricture-market-6001

Regional Outlook

In the reports of MRFR, the global urethral structural market has covered the leading regions for their market share of North America, which includes the U.S., Canada, and Mexico, Europe; which includes France, Italy, Germany, the U.K., Asia Pacific; which includes China, India, Japan, South Korea, and the Middle East & Africa; which consists of the Middle East and Africa.

Reports tell that North American region presently holds the largest market share and will continue to be on the same position in the years to come. The growth of the market here is attributed to the practice of sophisticated treatment in several health facilities in the US and other countries. Here, it has been observed that medical facilities are flouring rapidly due to continuous research and developments happening. By this, medical provisions hold massive potential for the future growth of the market in the US. On the other hand, technology has also supported the constant product development which is another reason for the growth of the market. Recently, with the usage of smartphone-based tools that detect urethral blockage is highly being used for patients for testing and curing while residing at home.

Whereas, the Europe market is also anticipated to proliferate suggestively during the forecast period owing to the high accessibility of advanced treatment facilities and healthcare expenditure in a larger scale is making ways for the market to expand substantially.

The market of global urethral structural in the Asia Pacific is observed to gain upward trajectory, which is attributed to growing expensive equipment and infrastructure, along with increasing research and development initiatives to progress the quality and effectiveness of new and modern instrumentations. Countries such as India and China are contributing massively to the market expansion due to the swift expansion of healthcare infrastructure and surging demand for treatment services.

Furthermore, the Middle East and Africa market are also expected to experience a steady growth rate driven by the mounting availability of new and advanced diagnostic and treatment methods.

[sfplhormelcenter]

Dr. Dillon's "Out of the Ordinary: A Life of Gender and Spiritual Transitions" [Call #: BD5876A] can be viewed on the 3rd floor by using the page desk or checked out with General Collections

Dr. Laurence Michael Dillon, born May 1st, 1915 in Folkestone in Kent, England was a physician as well as the first transgender male to undergo phalloplasty surgery. A tomboy from early childhood and throughout college in 1939, Dillon became the first documented female to male transgender person to begin hormone replacement therapy. Shortly after beginning hormone tablets, he started seeing a therapist who unfortunately violated his confidentiality and gossiped around town about Dillon's desire to live as a male full time. As a result of this breach of trust, a humiliated Dillon decided to move to Bristol and took up work in an auto garage where he passed as a male despite still legally being considered female.

Dillon’s life would change forever while in the Royal Infirmary for a head injury resulting from a fainting spell due to Hypoglycemia when he connected with a plastic surgeon, who performed a double mastectomy (top surgery) for him and provided him with a physician’s letter that allowed him to amend his birth certificate. While in the hospital Dillon also met with Dr. Harold Gillies, who agreed to perform a phalloplasty surgery on Dillon after perfecting his techniques on injured WWII veterans and intersex people.

In 1946, Gillies diagnosed Dillon with extreme hypospadias to hide the fact that Dillon was transgender from the public and allow him to operate on Dillon without scrutiny or legal troubles. Between 1946 to 1949, Gillies performed at least (if not more) 13 surgeries on Dillon some of which resulted in complications that left Dillon with a limp. After surgery, Dillon felt much more comfortable socializing and was known for his love of dancing, and while modern transgender men often seek surgery for a more cisnormative romantic life, Dillon avoided forming close relationships with women at all costs for fear of his revealing his trans status. His personal belief that "one must not lead a girl on if one could not give her children.” allowed him to enact misogynistic behaviors without shame and prevented women from being attracted to him.

Later in life, Dillon published a book about transgender people titled, Self: A Study in Endocrinology and Ethics and while Dillon didn’t reveal his transgender history in the book, it was splashed all over the newspapers when two prominent genealogical guidebooks respectively listed him as male and female.  The unwanted press attention due to this very public revelation of his transgender status led Dillon to flee to India where he immersed himself in Buddhist studies and adopted the new name, Sramanera Jivaka. However, he was refused ordination because of his transgender status and moved to Ladakh, where he was ordained a novice monk and took the name Lobzang Jivaka. In his final years, he devoted his time to Buddhism and writing publishing four books on Buddhism. In 1962, shortly after his visa expired his health started to fail, likely because of prolonged term oral testosterone use and his simple vegetarian diet and sadly he died after being admitted to a hospital in Dalhousie, India.

Sources: https://transguys.com/features/ftm-trans-history

https://www.themaven.net/transgenderuniverse/articles/people-profile-michael-dillon-KSmh4VDQQkaSteTnmruPvQ?full=1

https://en.wikipedia.org/wiki/Michael_Dillon

[specialisthospitals]

Hypospadias Surgery Cost in Kerala

Searching for the Best Hypospadias Surgery Cost in Kerala, Specialists hospital offers the best Hypospadias Surgery in Kerala

[indialaparoscopysugerysite]